ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

16,475Medicare Part D Prescriptions Filled, Including Refills

Rank: 23 out of 973

$640K Total Retail Price of All Prescriptions

Rank: 58 out of 973

364 Patients Receiving at Least One Drug in Part D
90%Patients 65 Years and Older
34% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Kansas
Lower avg

Schedule Two
Controlled Substances

10% of this provider’s 364 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

21% of this provider’s 364 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

2% of this provider’s 14,884 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

18% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$39 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

45 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Kansas
LEVOTHYROXINE SODIUM 769 717 1 2
FUROSEMIDE 656 633 2 6
OMEPRAZOLE 633 582 3 5
POTASSIUM CHLORIDE 566 538 4 9
SIMVASTATIN 475 445 5 1
LISINOPRIL 430 418 6 3
SPIRONOLACTONE 390 381 7 49
AMLODIPINE BESYLATE 386 365 8 7
METOPROLOL TARTRATE 380 360 9 13
ATENOLOL 362 323 10 16
FENTANYL 296 244 S2 11 53
HYDROCODONE-ACETAMINOPHEN 268 234 S3 12 4
SERTRALINE HCL 258 222 13 21
CITALOPRAM HBR 253 236 14 14
HYDROCHLOROTHIAZIDE 245 226 15 11
NAMENDA 242 240 16 31
METFORMIN HCL 232 220 17 8
WARFARIN SODIUM 229 218 18 10
RANITIDINE HCL 215 202 19 45
POLYETHYLENE GLYCOL 3350 213 199 20 36
ALLOPURINOL 205 174 21 29
TRAMADOL HCL 202 169 22 18
GABAPENTIN 191 182 23 12
METOCLOPRAMIDE HCL 180 141 24 93
DILTIAZEM ER 157 157 25 109
VENLAFAXINE HCL ER 154 154 26 95
ATORVASTATIN CALCIUM 133 112 27 15
SUCRALFATE 132 106 28 131
LEVOFLOXACIN 131 122 29 84
DONEPEZIL HCL 131 130 29 26
CARVEDILOL 121 111 31 27
GLIMEPIRIDE 115 110 32 41
TRIAMTERENE-HCTZ 108 88 33 51
PANTOPRAZOLE SODIUM 105 86 34 37
CLOPIDOGREL 96 96 35 44
METOPROLOL SUCCINATE 95 95 36 17
ALENDRONATE SODIUM 94 90 37 24
NORTRIPTYLINE HCL 93 70 38 313
LANTUS 89 78 39 39
EXELON 87 87 40 117
LOSARTAN POTASSIUM 83 83 41 19
OXYBUTYNIN CHLORIDE 83 61 41 92
CIPROFLOXACIN HCL 83 77 41 57
PROPRANOLOL HCL 81 78 44 97
BENAZEPRIL HCL 81 81 44 62
PREDNISONE 81 73 44 33
ENALAPRIL MALEATE 80 68 47 55
CELEBREX 79 68 48 91
ZOLPIDEM TARTRATE 79 65 48 20
DOXYCYCLINE HYCLATE 77 68 50 96
DIGOXIN 76 76 51 32
MIRTAZAPINE 75 69 52 43
RISPERIDONE 73 68 53 65
TRAZODONE HCL 72 68 54 48
ISOSORBIDE MONONITRATE ER 71 71 55 85
AMLODIPINE BESYLATE-BENAZEPRIL 71 71 55 80
TERAZOSIN HCL 71 66 55 112
GLYBURIDE 69 69 R 58 59
DICLOFENAC SODIUM 67 31 59 108
VYTORIN 67 48 59 154
TAMSULOSIN HCL 67 52 59 28
CARBIDOPA-LEVODOPA 65 53 62 71
ACETAMINOPHEN-CODEINE 63 43 S3 63 134
INSULIN SYRINGE 62 62 64 153
PRAVASTATIN SODIUM 61 52 65 22
PLAVIX 61 61 65 78
CYCLOBENZAPRINE HCL 59 18 R 67 42
GEMFIBROZIL 58 58 68 83
BUMETANIDE 55 51 69 103
CEPHALEXIN 55 52 69 75
NEXIUM 54 54 71 30
NITROFURANTOIN MONO-MACRO 53 42 72 185
FAMOTIDINE 51 41 73 61
AMITRIPTYLINE HCL 50 46 R 74 52
KETOCONAZOLE 50 47 74 219
FLUTICASONE PROPIONATE 50 49 74 35
OXYCODONE-ACETAMINOPHEN 50 44 S2 74 89
HUMALOG 50 50 74 127
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 5, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.